NDC 53346-1359

DR. RECKEWEG R59 Vesiculine Combination product

Calcarea Carbonica 12x, Fucus Vesiculosus 4x, Graphites 12x, Natrum Sulphuricum 4x, Spongia Tosta 4x

DR. RECKEWEG R59 Vesiculine Combination product is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Pharmazeutische Fabrik Dr. Reckeweg & Co. The primary component is Oyster Shell Calcium Carbonate, Crude; Fucus Vesiculosus; Graphite; Sodium Sulfate; Spongia Officinalis Skeleton, Roasted.

Product ID53346-1359_f531edcf-42bc-4af6-a613-74622bbab093
NDC53346-1359
Product TypeHuman Otc Drug
Proprietary NameDR. RECKEWEG R59 Vesiculine Combination product
Generic NameCalcarea Carbonica 12x, Fucus Vesiculosus 4x, Graphites 12x, Natrum Sulphuricum 4x, Spongia Tosta 4x
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1986-06-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NamePHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Substance NameOYSTER SHELL CALCIUM CARBONATE, CRUDE; FUCUS VESICULOSUS; GRAPHITE; SODIUM SULFATE; SPONGIA OFFICINALIS SKELETON, ROASTED
Active Ingredient Strength12 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 53346-1359-5

50 mL in 1 BOTTLE (53346-1359-5)
Marketing Start Date1986-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53346-1359-5 [53346135905]

DR. RECKEWEG R59 Vesiculine Combination product LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1986-06-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
OYSTER SHELL CALCIUM CARBONATE, CRUDE12 [hp_X]/50mL

OpenFDA Data

SPL SET ID:f42a99a1-ef5a-45a5-af4e-9493b6c14450
Manufacturer
UNII
UPC Code
  • 0669330001165

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.